Michael J. Peerless

The defendants brought a motion for leave to appeal the decision of Justice Belobaba dated October 29, 2019.

The Divisional Court dismissed the motion for leave to appeal.

Costs of the motion were awarded to the responding parties, the plaintiffs, fixed in the amount of $35,000.

The appellant appealed the dismissal of his motion to certify a class action against a smartphone manufacturer regarding a product recall.

The Divisional Court upheld the motion judge's findings that the pleadings failed to disclose a viable cause of action due to lack of particulars and lack of contractual privity.

The court also agreed that the appellant failed to establish common issues, as the expert evidence on damages was not grounded in the facts of the case and individual trials would be necessary to determine harm.

The appeal was dismissed.

A corn grower who neither purchased nor planted genetically modified corn seed brought a proposed class action against the seed manufacturer for negligence, negligent misrepresentation, and breach of the Competition Act.

The manufacturer had commercialized the seed in North America before obtaining approval in China.

The seed's traits commingled with all North American corn, causing China to ban all North American corn imports, resulting in a market glut and price collapse.

The motion judge struck all claims.

The Court of Appeal allowed the appeal in part, reinstating the negligence claim for premature commercialization while upholding dismissal of the misrepresentation and Competition Act claims.

The plaintiff sought certification of a class action against Ford Motor Company and related entities, alleging false, misleading, or deceptive representations regarding the fuel consumption of 2013 and 2014 model year vehicles.

The claim, for $1.5 billion, was based on violations of the Competition Act and the Consumer Protection Act, asserting that Ford understated fuel consumption by using an outdated 2-Cycle Test instead of the more accurate 5-Cycle Test.

The court certified the action, finding that the pleadings disclosed viable causes of action, there was an identifiable class, common issues existed, a class proceeding was the preferable procedure, and the representative plaintiff was suitable.

The plaintiff, a commercial corn grower, brought a proposed class action against the defendants, manufacturers of genetically modified corn seeds (Agrisure), alleging negligence and breach of the Competition Act.

The plaintiff claimed that North American corn prices fell due to China's rejection of corn shipments containing unapproved Agrisure, causing economic loss to non-Agrisure farmers.

The defendants moved to strike the claim under Rule 21, arguing no duty of care existed for pure economic loss.

The court granted the motion, finding that while the claim was framed in misrepresentation, the plaintiff's reliance on the defendants' alleged undertaking not to introduce Agrisure without global approvals was unreasonable, as commingling was inevitable and preventing it would require withholding the product from the domestic market, which had regulatory approval.

The court also noted the risk of indeterminate liability and the illogical elevation of foreign approvals over domestic ones.

The representative plaintiffs moved for approval of a $2.375 million settlement in a class action concerning the under-dosing of chemotherapy drugs at several hospitals.

The defendants, who supplied and administered the drugs, denied liability, arguing there was no evidence of clinical impact on patient outcomes and that the plaintiffs' psychological harm did not meet the legal threshold for a recognizable psychiatric illness.

The court approved the settlement, finding it fair, reasonable, and in the best interests of the class given the significant litigation risks, the lack of evidence showing clinical harm, and the recommendations of experienced class counsel.

The court also approved class counsel's requested fees of $400,000.

In a proposed pharmaceutical products liability class proceeding, the defendants moved for summary judgment before certification.

The plaintiffs alleged that a testosterone gel caused serious cardiovascular events, was improperly marketed for age-related low testosterone, and generated claims in negligence, failure to warn, unjust enrichment, waiver of tort, and pure economic loss.

The court held that although the evidence established an association and biological plausibility, it did not establish general causation on a balance of probabilities.

The court further held that an association may trigger a duty to warn, but any failure-to-warn claim still failed because causation was not proven.

The claims for unjust enrichment, waiver of tort, and pure economic loss also failed factually and legally, and the action was dismissed.

The plaintiffs, former inmates of the Elgin-Middlesex Detention Centre, brought a motion to certify a class action against the provincial Crown alleging systemic negligence and Charter breaches resulting from overcrowding and inadequate supervision.

The Crown opposed certification and moved to strike portions of the claim and evidence.

The court struck the claim for breach of fiduciary duty but found the pleadings otherwise disclosed reasonable causes of action in systemic negligence and Charter breaches.

The court admitted the plaintiffs' evidence for the limited purpose of the certification motion and concluded that all criteria under section 5(1) of the Class Proceedings Act were met.

The motion for certification was granted.

The plaintiffs sought court approval to certify a class action for settlement purposes and to approve the settlement and legal fees.

The class action, limited to specific pelvic mesh products (Avaulta, Align, Ajust), was certified for settlement.

The court approved the $2.475 million settlement after class counsel provided sufficient information demonstrating its reasonableness, addressing initial judicial concerns about the lack of detail.

Legal fees of $742,500 (30% contingency) plus disbursements and taxes were also approved, consistent with the court's principled approach to class counsel compensation.

The plaintiffs moved for certification of a products liability class action against the defendants regarding pelvic mesh products used to treat pelvic organ prolapse and stress urinary incontinence.

The court dismissed the certification motion, finding that while the plaintiffs satisfied the cause of action, identifiable class, and representative plaintiff criteria, they failed to establish some-basis-in-fact for the commonality and preferable procedure criteria due to the multifarious nature of the 19 different products involved.

The dismissal was made subject to an 'Alternatives Motion' to allow the plaintiffs to propose continuing the proceeding in an altered form.

The plaintiffs sought certification of a proposed class action against a pharmaceutical manufacturer regarding the oral contraceptives Yasmin and YAZ.

The proposed class included Ontario residents prescribed and using the drugs prior to November 30, 2011, and derivative claimants under the Family Law Act.

The plaintiffs alleged negligence in the design, testing, marketing, and warning associated with the drospirenone component, claiming it posed greater risks than other oral contraceptives.

The court held that the pleadings disclosed viable causes of action, that the proposed class and common issues were sufficiently defined, and that a class proceeding was the preferable procedure under the Class Proceedings Act, 1992.

Certification was granted with certain modifications to the class definition and litigation plan.

The plaintiffs, autistic children and their parents, commenced a proposed class proceeding alleging the provincial government and several school boards failed to provide or fund Applied Behavioural Analysis therapy and related services within Ontario’s education system, contrary to the Charter.

After earlier rulings struck most causes of action and the Court of Appeal limited the remaining claims, the plaintiffs moved to discontinue the proceeding under s. 29 of the Class Proceedings Act.

The court reviewed the legal framework governing discontinuance of proposed class proceedings, focusing on whether the discontinuance would prejudice putative class members.

Finding no evidence of improper purpose, prejudice to class members, or objection from notified parties, the court approved the discontinuance on consent and without costs.

The appellants, representing children with autism and their families, appealed a motion judge's decision striking several causes of action from their proposed class proceeding against Ontario and several school boards.

The claims challenged the provision of autism and education services, alleging negligence, breach of fiduciary duty, and Charter violations.

The Court of Appeal allowed the appeal in part.

It struck the age-based discrimination claim without leave to amend, citing stare decisis from the Wynberg decision.

The disability discrimination claim and the claim for Charter damages were struck with leave to amend due to a lack of precision in the pleadings.

The court also granted leave to amend the negligence claim against the school boards regarding operational aspects of the programs, but otherwise dismissed the appeal and cross-appeal.